TSX: IGX
TSX: IGX
  flec Erectile Dysfunction
(Tadalafil)
Formulation Development
Clinical
 
Filing
 
Launch
rizaport10

INDICATED FOR ERECTILE DYSFUNCTION

Tadalafil VersaFilm® is a new product opportunity formulated using IntelGenx’s proprietary thin film technology and tadalafil, one of the three main PDE5 inhibitors available for the treatment of erectile dysfunction.

After conducting clinical trials of various tadalafil film formulations to optimize pharmacokinetics and formulation, IntelGenx’s latest formulation successfully demonstrated bioequivalence to the Cialis® tablet in a pilot study. IntelGenx’s aims to have its Tadalafil film ready for market launch ahead of the Cialis® patent expiry.

Rizaport Logo

 

image izq
No need to swallow a pill
image izq
No need for water
image izq
proprietary thin film
technology
image izq
bioequivalence to the Cialis® tablet in a pilot study
 
TADALAFIL
   

 First erectile dysfunction film product on the market
Erectile dysfunction molecule with the longest duration of action
Less food effects
Does not require water intake

vsrizap
vs tools
Layer14
 

TADALAFIL

Learn more about Tadalafil VersaFilmTM.

Visit the website
versafilm

PARTNER WITH US >>

IntelGenx is currently looking for a partnership or alliance opportunity to complete development and commercialize tadalafil VersaFilm®.

Available for partnering

PRODUCT WARNING

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

PRESCRIBING INFORMATION

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.